Skip to content
Carboxymethylcellulose
Carboxymethylcellulose is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
eye diseasesD005128
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
good neighbor pharmacy lubricant eye dropsOTC monograph final2023-06-01
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
dry eye syndromes—D015352H04.12
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
57 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dry eye syndromesD015352H04.12—3812930
Prostatic neoplasmsD011471C61———2—2
Keratoconjunctivitis siccaD007638EFO_1000906———2—2
Macular edemaD008269———1—1
Retinal vein occlusionD012170EFO_1001157H34.81———1—1
Macular degenerationD008268EFO_0001365H35.30———1—1
CataractD002386EFO_0001059H26.9———1—1
MyopiaD009216H52.1———1—1
Cesarean sectionD002585———1—1
Obstetric deliveryD036861———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Viral conjunctivitisD003236EFO_0008571B30—11——1
Refractive errorsD012030EFO_0003908H52.7—11——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Corneal neovascularizationD016510EFO_1000880H16.422———2
GlioblastomaD005909EFO_000051511———1
AsthenopiaD001248H53.1411———1
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypoglycemiaD007003HP_0001943E16.2————11
Irritable bowel syndromeD043183EFO_0000555K58————11
ConstipationD003248HP_0002019K59.0————11
ObesityD009765EFO_0001073E66.9————11
Non-alcoholic fatty liver diseaseD065626EFO_0003095K75.81————11
Healthy volunteers/patients—————11
Bullous pemphigoidD010391EFO_0007187L12————11
PemphigusD010392EFO_1000749L10————11
Fecal incontinenceD005242R15————11
BurnsD002056T30.0————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCARBOXYMETHYLCELLULOSE
INNcarmellose
Description
Carboxymethyl cellulose (CMC) or cellulose gum is a cellulose derivative with carboxymethyl groups (-CH2-COOH) bound to some of the hydroxyl groups of the glucopyranose monomers that make up the cellulose backbone. It is often used as its sodium salt, sodium carboxymethyl cellulose. It used to be marketed under the name Tylose, a registered trademark of SE Tylose.
Classification
Unknown
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID9000-11-7
RxCUI2062
ChEMBL IDCHEMBL1909054
ChEBI ID—
PubChem CID—
DrugBankDB11059
UNII ID05JZI7B19X (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 14,478 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
2,593 adverse events reported
View more details